AGILeBiotics raised next round of investment to advance novel antibiotic candidates into pre-clinical development
On 18th of July 2018, a deal was closed securing a joined investment from five regional investors, i.e. RUG Houdstermaatschappij BV, Stichting Ir. G.J. Smid Fonds BV, and Hanzepoort BV, Carduso Capital BV and Pharma Connect Capital BV. Whereas, the first three investment companies joined AGILeBiotics already in March 2017, Carduso Capital and Pharma Connect Capital become new shareholders with the recently acquired investment.
Full PR available here